Stockreport

NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines [Yahoo! Finance]

Novavax, Inc.  (NVAX) 
Last novavax, inc. earnings: 3/11 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.novavax.com/investor-relations
PDF The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax's currently authorized COVID-19 vaccine and a licensed [Read more]